Brickell Biotech Inc expected to post a loss of 6  cents a share - Earnings Preview

Fresh Tracks Therapeutics

11/05/2022 01:43

* Brickell Biotech Inc  BBI.OQ   BBI.O  is expected to show
a rise
in quarterly revenue when it reports  results on May 12. 
    * The Boulder Colorado-based  company is expected to report 
a
745.6% increase in revenue to $143.75 thousand from $17 thousand
a year ago, according to the mean estimate from 4 analysts,
based on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Brickell Biotech
Inc is
for a loss of 6 cents per share. For the same quarter last year,
the company reported a loss of 15 cents per share.
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 4 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts had risen by
about 12.1%
in the last three months. ​
    * Wall Street's median 12-month price target for Brickell
Biotech
Inc is $2​, above​ its last closing price of $0.21. ​​​
    * Previous quarterly performance (using preferred earnings
measure
in US dollars). ​

 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Dec. 31 2021  -0.09       -0.08      -0.06     Beat    29.4
 Sep. 30 2021              -0.12      -0.16     Missed  -28
 Jun. 30 2021  -0.14       -0.12      -0.16     Missed  -28​
 Mar. 31 2021  -0.11       -0.11      -0.15     Missed  -30.4
 ​​Dec.        -0.09       -0.09      -0.15     Missed  -66.7
 31 2020                                                
 Sep. 30 2020  -0.19       -0.18      -0.15     Beat    18.9​
 This summary was machine generated May 11 at 00:43 GMT.  All
figures in US dollars  unless otherwise stated